These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 31585944)
21. A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A beta-haemolytic streptococci. Carbon C; Chatelin A; Bingen E; Zuck P; Rio Y; Guetat F; Orvain J J Antimicrob Chemother; 1995 Jun; 35(6):843-54. PubMed ID: 7559195 [TBL] [Abstract][Full Text] [Related]
22. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Lennon DR; Farrell E; Martin DR; Stewart JM Arch Dis Child; 2008 Jun; 93(6):474-8. PubMed ID: 18337284 [TBL] [Abstract][Full Text] [Related]
23. Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V. Ovetchkine P; Levy C; de la Rocque F; Boucherat M; Bingen E; Cohen R Eur J Pediatr; 2002 Jul; 161(7):365-7. PubMed ID: 12111186 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis. Norrby SR; Quinn J; Rangaraju M; Leroy B Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873 [TBL] [Abstract][Full Text] [Related]
25. Relief of symptoms in patients with group A beta-hemolytic streptococcus tonsillopharyngitis: comparison between telithromycin and penicillin V. Norrby SR; Chang J; Stewart JA; Brumpt I; Conway DP Scand J Infect Dis; 2003; 35(4):223-5. PubMed ID: 12839147 [TBL] [Abstract][Full Text] [Related]
26. Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis. Dajani AS; Kessler SL; Mendelson R; Uden DL; Todd WM Pediatr Infect Dis J; 1993 Apr; 12(4):275-9. PubMed ID: 8483620 [TBL] [Abstract][Full Text] [Related]
27. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. Schaad UB; Kellerhals P; Altwegg M; Pediatr Infect Dis J; 2002 Apr; 21(4):304-8. PubMed ID: 12075761 [TBL] [Abstract][Full Text] [Related]
28. A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group. Tack KJ; Hedrick JA; Rothstein E; Nemeth MA; Keyserling C; Pichichero ME Arch Pediatr Adolesc Med; 1997 Jan; 151(1):45-9. PubMed ID: 9006528 [TBL] [Abstract][Full Text] [Related]
29. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age. Scholz H Chemotherapy; 2004 Apr; 50(1):51-4. PubMed ID: 15084807 [TBL] [Abstract][Full Text] [Related]
30. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V. Deeter RG; Kalman DL; Rogan MP; Chow SC Clin Ther; 1992; 14(5):740-54. PubMed ID: 1468091 [TBL] [Abstract][Full Text] [Related]
31. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Orrling A; Stjernquist-Desatnik A; Schalén C; Kamme C Scand J Infect Dis; 1994; 26(5):535-41. PubMed ID: 7855551 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study. Quinn J; Ruoff GE; Ziter PS Clin Ther; 2003 Feb; 25(2):422-43. PubMed ID: 12749505 [TBL] [Abstract][Full Text] [Related]
33. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study. Jorgensen DM Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975 [TBL] [Abstract][Full Text] [Related]
34. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Brook I; Gober AE Arch Otolaryngol Head Neck Surg; 1995 Dec; 121(12):1405-9. PubMed ID: 7488371 [TBL] [Abstract][Full Text] [Related]
35. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Cohen R Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076 [TBL] [Abstract][Full Text] [Related]
36. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group. Brown RJ; Batts DH; Hughes GS; Greenwald CA Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915 [TBL] [Abstract][Full Text] [Related]
37. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population. McCarty J Am J Med; 1992 Jun; 92(6A):74S-79S. PubMed ID: 1621750 [TBL] [Abstract][Full Text] [Related]
38. Agreement between rapid antigen detection test and culture for group A streptococcus in patients recently treated for pharyngotonsillitis - a prospective observational study in primary care. Rystedt K; Hedin K; Tyrstrup M; Skoog-Ståhlgren G; Edlund C; Giske CG; Gunnarsson R; Sundvall PD Scand J Prim Health Care; 2023 Mar; 41(1):91-97. PubMed ID: 36880344 [TBL] [Abstract][Full Text] [Related]
39. Cefetamet pivoxil in the treatment of pharyngitis/tonsillitis in children and adults. Guggenbichler JP Drugs; 1994; 47 Suppl 3():27-33; discussion 34. PubMed ID: 7518764 [TBL] [Abstract][Full Text] [Related]
40. Phenoxymethylpenicillin two or three times daily for tonsillitis with beta-haemolytic streptococci group A: a blinded, randomized and controlled clinical study. Fyllingen G; Arnesen AR; Biermann C; Kaarby O; Romfo O; Rønnevig J; Aaserud J Scand J Infect Dis; 1991; 23(5):553-8. PubMed ID: 1767251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]